SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
April 23 2024 - 10:29AM
SOPHiA GENETICS, a cloud-native software company and a leader in
data-driven medicine, today announced it will release its financial
results for the first quarter of fiscal year 2024 before U.S.
markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS
will host a conference call to discuss its financial results as
well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00
p.m. (14:00) CET.
The call will be webcast live on the SOPHiA GENETICS
Investor Relations website. Additionally, a replay will be
available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native
healthcare technology company on a mission to expand access to
data-driven medicine by using AI to deliver world-class care to
patients with cancer and rare disorders across the globe. It is the
creator of SOPHiA DDM™, a platform that analyzes complex genomic
and multimodal data and generates real-time, actionable insights
for a broad global network of hospital, laboratory, and biopharma
institutions. For more information, visit SOPHiAGENETICS.COM
and connect with us on LinkedIn.
Investor Contact
Kellen Sanger
IR@sophiagenetics.com
Media Contact
Kelly Katapodis
media@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Oct 2023 to Oct 2024